Resveratrol and cancer: a review

J F Savouret1, M Quesne

  • 1INSERM unité 135, Hopital de Bicêtre CHU level 3, Le Kremlin-Bicêtre, France. savouret@kb.inserm.fr

Insights

Resveratrol, a stilbene phytoalexin, offers promising research directions for cancer prevention and treatment. Its properties are particularly relevant for understanding and combating xenobiotic-induced carcinogenesis.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Resveratrol is a naturally occurring stilbene phytoalexin found in various plants.
  • Phytoalexins are compounds produced by plants to protect against pathogens.
  • Resveratrol has demonstrated diverse biological activities, including antioxidant and anti-inflammatory effects.

Purpose of the Study:

  • To explore the chemopreventive and chemotherapeutic potential of Resveratrol.
  • To investigate the role of Resveratrol in the context of xenobiotic-related carcinogenesis.
  • To highlight Resveratrol as a subject for novel research avenues.

Main Methods:

  • Literature review of Resveratrol's properties and biological activities.
  • Analysis of studies focusing on Resveratrol's effects on carcinogenesis.
  • Examination of Resveratrol's interaction with xenobiotic metabolism and pathways.

Main Results:

  • Resveratrol exhibits multifaceted properties applicable to cancer chemoprevention and chemotherapy.
  • Evidence suggests Resveratrol's potential in mitigating risks associated with xenobiotic-induced cancers.
  • The compound's mechanisms of action warrant further in-depth investigation.

Conclusions:

  • Resveratrol presents significant opportunities for developing new strategies in cancer prevention and treatment.
  • Further research into Resveratrol's role in xenobiotic carcinogenesis is crucial.
  • The therapeutic potential of Resveratrol in oncology is a promising area for scientific exploration.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...